000			03033nam a22003735i 4500
001			82607
003			ES-MaUEC
005			20230202103514.0
008			160913t2015 ja a s |||| 0|eng d
020			_a9784431549772
040			_aES-MaUEC
050		4	_aRC280.E8 _b2015 EB
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a616.994
245	0	0	_aEsophageal squamous cell carcinoma : _bdiagnosis and treatment _cedited by Nobutoshi Ando
260			_aTokyo _bSpringer _ccop. 2015
300			_a1 recurso en línea (X, 309 p.) _bil.
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
520			_aEsophageal cancer causes an estimated 386,000 deaths worldwide and is the sixth most common cause of death for men. The background characteristics of esophageal cancer treatment are markedly different between Asian and Western countries, however. In tumor histology, squamous cell carcinoma associated with smoking and alcohol consumption is overwhelmingly prevalent in Asia, whereas adenocarcinoma associated with Barrettâ€{u382D}etaplasia is markedly prevalent in the West. In Asia, especially in Japan, the key persons who play important roles in the management of esophageal cancer patients are surgeons; in the West those roles are filled by medical and radiation oncologists as well as surgeons. The philosophy of surgeons regarding cancer surgery varies from locoregional to local tumor control, particularly in focusing on lymph node dissection. Physiciansâ€{u0870}proach to surgical adjuvant therapy differs, therefore, between Asia and the West. Considering these Eastâ€{u7973}t differences in esophageal cancer treatment, the currently available results of Western evidence should not be considered directly applicable to esophageal cancer in Asia. In this book, the authors discuss the knowledge base in Japan in terms of treatment of esophageal squamous cell carcinoma. Since this volume contains a wide spectrum of current information and addresses topics surrounding the treatment of patients with esophageal squamous cell carcinoma, it is highly relevant to Asian physicians and researchers as well as to their counterparts in the West.
942			_2lcc _cLE
650		7	_aEsófago _xCáncer _9185293 _0comprobar BNE19912567471 _2embne
700	1		_aAndo, Nobutoshi _eeditor literario _995649 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-4-431-54977-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9784431549772
907			_a.b12912475 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b13-09-16 _cm _dz _ea _feng _gja _h0
945			_aRC280.E8 E86 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1158015x _z06-04-17
999			_c82607 _d82607 _x1